Literature DB >> 22114912

Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.

K Blackstone1, D J Moore, R K Heaton, D R Franklin, S P Woods, D B Clifford, A C Collier, C M Marra, B B Gelman, J C McArthur, S Morgello, D M Simpson, M Rivera-Mindt, R Deutsch, R J Ellis, J Hampton Atkinson, I Grant.   

Abstract

Three types of HIV-associated neurocognitive disorders (HAND) exist that are distinguished by presence and severity of impairment in cognitive and everyday functioning. Although well-validated neurocognitive measures exist, determining impairment in everyday functioning remains a challenge. We aim to determine whether Self-Report measures of everyday functioning are as effective in characterizing HAND as Performance-Based measures. We assessed 674 HIV-infected participants with a comprehensive neurocognitive battery; 233 met criteria for a HAND diagnosis by having at least mild neurocognitive impairment. Functional decline was measured via Self-Report and Performance-Based measures. HAND diagnoses were determined according to published criteria using three approaches to assess functional decline: (1) Self-Report measures only, (2) Performance-Based measures only, and (3) Dual-method combining Self-Report and Performance-Based measures. The Dual-method classified the most symptomatic HAND, compared to either singular method. Singular method classifications were 76% concordant with each other. Participants classified as Performance-Based functionally impaired were more likely to be unemployed and more immunosuppressed, whereas those classified as Self-Report functionally impaired had more depressive symptoms. Multimodal methods of assessing everyday functioning facilitate detection of symptomatic HAND. Singular Performance-Based classifications were associated with objective functional and disease-related factors; reliance on Self-Report classifications may be biased by depressive symptoms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22114912      PMCID: PMC3882265          DOI: 10.1017/S135561771100141X

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  38 in total

1.  The role of cognition, depression, and awareness of deficit in predicting geriatric rehabilitation patients' IADL performance.

Authors:  J LaBuda; P Lichtenberg
Journal:  Clin Neuropsychol       Date:  1999-08       Impact factor: 3.535

Review 2.  The incremental validity of psychological testing and assessment: conceptual, methodological, and statistical issues.

Authors:  John Hunsley; Gregory J Meyer
Journal:  Psychol Assess       Date:  2003-12

3.  Is the influence of social desirability on patients' self-reported adherence overrated?

Authors:  Glenn Wagner; Loren G Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

Review 4.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

5.  Optimal recall period and response task for self-reported HIV medication adherence.

Authors:  Minyi Lu; Steven A Safren; Paul R Skolnik; William H Rogers; William Coady; Helene Hardy; Ira B Wilson
Journal:  AIDS Behav       Date:  2007-06-19

6.  Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.

Authors:  C E Schwartz; E Kozora; Q Zeng
Journal:  Ann Behav Med       Date:  1996-09

7.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

8.  Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change.

Authors:  Lucette A Cysique; Donald Franklin; Ian Abramson; Ronald J Ellis; Scott Letendre; Ann Collier; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2011-03-07       Impact factor: 2.475

9.  Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus.

Authors:  R L Mapou; W A Law; A Martin; D Kampen; A M Salazar; J R Rundell
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1993       Impact factor: 2.198

10.  [Neuropsychological performance in patients with human inmunodeficiency (HIV) and hepatitis C virus (HCV) coinfection].

Authors:  J M Failde Garrido; M Rodríguez Alvarez; J López Castro; M A Simón López
Journal:  Neurologia       Date:  2009-04       Impact factor: 3.109

View more
  64 in total

1.  Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.

Authors:  Doyle E Patton; Steven Paul Woods; Donald Franklin; Jordan E Cattie; Robert K Heaton; Ann C Collier; Christina Marra; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant
Journal:  AIDS Behav       Date:  2012-11

2.  Apathy is associated with lower mental and physical quality of life in persons infected with HIV.

Authors:  Rujvi Kamat; Steven Paul Woods; Marizela V Cameron; Jennifer E Iudicello
Journal:  Psychol Health Med       Date:  2016-01-19       Impact factor: 2.423

3.  A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.

Authors:  J A Joska; J Witten; K G Thomas; C Robertson; M Casson-Crook; H Roosa; J Creighton; J Lyons; J McArthur; N C Sacktor
Journal:  AIDS Behav       Date:  2016-08

4.  Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Robert K Heaton; Knut A Hestad
Journal:  AIDS Behav       Date:  2017-06

5.  Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.

Authors:  Tricia H Burdo; Allison Weiffenbach; Steven P Woods; Scott Letendre; Ronald J Ellis; Kenneth C Williams
Journal:  AIDS       Date:  2013-06-01       Impact factor: 4.177

6.  Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV.

Authors:  Stephanie Chiao; Howard J Rosen; Krista Nicolas; Lauren A Wendelken; Oscar Alcantar; Katherine P Rankin; Bruce Miller; Victor Valcour
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-20       Impact factor: 2.205

7.  Habitual prospective memory in HIV disease.

Authors:  Katie L Doyle; Erica Weber; Erin E Morgan; Shayne Loft; Clint Cushman; Javier Villalobos; Elaine Johnston; Steven Paul Woods
Journal:  Neuropsychology       Date:  2015-03-02       Impact factor: 3.295

8.  Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.

Authors:  Jordan E Cattie; Steven Paul Woods; Jennifer E Iudicello; Carolina Posada; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

9.  Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

Authors:  Igor Grant; Donald R Franklin; Reena Deutsch; Steven P Woods; Florin Vaida; Ronald J Ellis; Scott L Letendre; Thomas D Marcotte; J H Atkinson; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; John A McCutchan; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Davey M Smith; Robert K Heaton
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

10.  Prospective memory deficits are associated with poorer everyday functioning in Parkinson's disease.

Authors:  Eva Pirogovsky; Steven Paul Woods; J Vincent Filoteo; Paul E Gilbert
Journal:  J Int Neuropsychol Soc       Date:  2012-07-30       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.